Prospective Genomic Profiling of Consecutive Meningiomas

This report presents prospective genomic profiling of 1,104 consecutive meningioma samples collected at a single academic medical center. The study aims to delineate the molecular architecture of meningiomas through comprehensive profiling of each tumor specimen, providing a large, consecutive dataset for analysis.

The available information indicates that the cohort comprises tumors prospectively obtained in an academic setting, but details on the specific molecular modalities used (such as sequencing platforms, panels, or assay types), the depth of sequencing, or the exact molecular classifications identified are not provided in the available summary. Consequently, the precise genomic alterations, frequency distributions, or correlations with clinical variables (e.g., tumor grade, patient demographics, or outcomes) cannot be stated.

The absence of explicit methodological and result data introduces uncertainty regarding how the molecular landscape was characterized and what actionable or descriptive conclusions were drawn. If further specifics from the full text are available, they would enable a more complete synthesis of the genomic architecture and its clinical relevance for meningiomas.